MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laurenza, A.
Right arrow Articles by Seamon, K. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laurenza, A.
Right arrow Articles by Seamon, K. B.

Stimulation of adenylate cyclase by water-soluble analogues of forskolin

A Laurenza, Y Khandelwal, NJ De Souza, RH Rupp, H Metzger and KB Seamon

Analogues of forskolin that are more soluble in water than forskolin have been synthesized and tested for their ability to interact with adenylate cyclase. These analogues are esterified with various heterocyclic amino acids at the 6 beta-hydroxyl position of forskolin or at the 6 beta-hydroxyl or 7 beta-hydroxyl position of 7-desacetyl forskolin. Analogues were tested for their ability to activate rat brain adenylate cyclase, activate detergent-solubilized rat brain adenylate cyclase, increase cyclic AMP in intact S49 wild-type cells, and inhibit the binding of 3H-forskolin to rat brain membranes. Forskolin activated rat brain adenylate cyclase with an EC50 of 4 microM and increased cyclic AMP in intact S49 cells with an EC50 of 5 microM. Analogues esterified at the 7 beta-hydroxyl position had EC50 values that ranged from 4 microM to 15 microM for activating adenylate cyclase in membranes and solubilized preparations, and for increasing cyclic AMP in S49 cells. Analogues esterified at the 6 beta-hydroxyl position with no acyl group at the 7 beta-hydroxyl position were generally less potent than the corresponding 7-acyl analogues with EC50 values that ranged from 30 microM to 100 microM. Interestingly, the diacyl analogues of forskolin containing an acetate group at the 7 beta- hydroxyl position and esterified with heterocyclic amino acids at the 6 beta-hydroxyl position were very potent at stimulating adenylate cyclase, with EC50 values that ranged from 1 microM to 25 microM. The 7- acyl analogues and the 6,7-diacyl analogues inhibited the binding of 3H- forskolin to rat brain membranes with IC50 values that ranged from 20 microM to 70 microM, while the 6-acyl analogues had much higher IC50 values that ranged from 100 nM to 375 nM. Aqueous solutions of forskolin were also produced by dissolving forskolin in solutions of hydroxypropyl-gamma-cyclodextrin. These aqueous solutions of forskolin were equipotent with alcoholic solutions of forskolin in stimulating adenylate cyclase. In conclusion, water-soluble derivatives of forskolin may be useful for increasing cyclic AMP in broken cell preparations or in intact cell preparations where the presence of organic solvents, which are necessary to solubilize forskolin, are detrimental. Alternatively, aqueous solutions of forskolin can be produced by dissolving forskolin in solutions of hydroxypropyl-gamma- cyclodextrin.

Volume 32, Issue 1, pp. 133-139, 07/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
C. Pinto, D. Papa, M. Hubner, T.-C. Mou, G. H. Lushington, and R. Seifert
Activation and Inhibition of Adenylyl Cyclase Isoforms by Forskolin Analogs
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 27 - 36.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. H. Zhang, S. C. Souza, K. V. Muliro, F. B. Kraemer, M. S. Obin, and A. S. Greenberg
Lipase-selective Functional Domains of Perilipin A Differentially Regulate Constitutive and Protein Kinase A-stimulated Lipolysis
J. Biol. Chem., December 19, 2003; 278(51): 51535 - 51542.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Q. Lin, J. Wu, and W. D. Willis
Effects of Protein Kinase A Activation on the Responses of Primate Spinothalamic Tract Neurons to Mechanical Stimuli
J Neurophysiol, July 1, 2002; 88(1): 214 - 221.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. E. Fox and P. E. Lloyd
Role of cAMP in the Short-Term Modulation of a Neuromuscular System in Aplysia
J Neurophysiol, March 1, 2000; 83(3): 1567 - 1579.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Q. Wang and J. Q. Zheng
cAMP-Mediated Regulation of Neurotrophin-Induced Collapse of Nerve Growth Cones
J. Neurosci., July 1, 1998; 18(13): 4973 - 4984.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Hamm-Alvarez, P. Kim, and M. Sheetz
Regulation of vesicle transport in CV-1 cells and extracts
J. Cell Sci., January 11, 1993; 106(3): 955 - 966.
[Abstract] [PDF]


Home page
ScienceHome page
P. Wagoner and B. Pallotta
Modulation of acetylcholine receptor desensitization by forskolin is independent of cAMP
Science, June 17, 1988; 240(4859): 1655 - 1657.
[Abstract] [PDF]


Home page
J. Physiol.Home page
E. A. Bukharaeva, D. Samigullin, E. Nikolsky, and F. Vyskocil
Protein kinase A cascade regulates quantal release dispersion at frog muscle endplate
J. Physiol., February 1, 2002; 538(3): 837 - 848.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1987 by the American Society for Pharmacology and Experimental Therapeutics